FAQs
Taysha Gene Therapies is located at 3000 Pegasus Park Drive, Suite 1430, Dallas, TX, 75247.
Our common stock is traded on the NASDAQ Global Select Market under the ticker symbol, TSHA.
Our initial public offering took place on September 24, 2020.
We do not expect to pay any cash or other dividends on our common stock neither now nor in the foreseeable future.
American Stock Transfer & Trust Company.
Our legal counsel is Cooley and Deloitte & Touche is our audit firm.
Our quarterly and annual reports, as well as other SEC filings, can be found on the Financials & Filings portion of the Investor Relations website or directly from the SEC at www.sec.gov.